Klaus Wilhardt - Corporate identity, Design, Logo/navnetræk og designguides
NMD Pharma
Investors — NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma, finalist i Life Sciences kategorien - EY Danmark
NMD Pharma Information | NMD Pharma Profile
Nete Huus's email & phone | NMD Pharma ApS's Senior Scientist email
NMD Pharma raises $47M in series A investment round from INKEF and existing investors, to advance treatments of neuromuscular disorders | Nordic 9
NMD Pharma on Vimeo
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma - Inkef capital
NMD Pharma A/S | LinkedIn
Well-financed biotech company to enter the clinic in 2020
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Prominent Canadian researcher in Denmark: Why I left a top job in California
Erhverv Aarhus - 照片| Facebook
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "
NMD Pharma A/S | LinkedIn
Management — NMD Pharma
NMD Pharma - PIR International
NMD Pharma - Capnova
NMD Pharma A/S | LinkedIn
Detailed Description | NMD-GPS
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis | MENAFN.COM
NMD Pharma
